Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mitochondrial Dysfunction: Pervasive Disease Driver, Therapeutic Target

Dr. Carlos M. Alvarez*
Universidad Nacional Autónoma de México, Dept. of Physiology, Mexico
*Corresponding Author: Dr. Carlos M. Alvarez, Universidad Nacional Autónoma de México, Dept. of Physiology, Mexico, Email: c.alvarez@unamphysio.mx

Citation:

Copyright:

 
To read the full article Peer-reviewed Article PDF image

Abstract

Mitochondrial dysfunction is a fundamental driver across numerous chronic diseases, including neurodegenerative disorders, metabolic syndromes, cancer, cardiovascular ailments, aging, and kidney diseases. These impairments manifest through disrupted energy production, calcium dysregulation, oxidative stress, and failures in mitochondrial dynamics and quality control like mitophagy. Importantly, this pervasive pathology often initiates a vicious cycle with chronic inflammation, exacerbating disease progression. Current research highlights promising therapeutic strategies, ranging from the fundamental benefits of exercise training in enhancing mitochondrial biogenesis and dynamics, to cutting-edge drug discovery efforts aimed at restoring mitochondrial health. These interventions offer significant potential to address a broad spectrum of conditions rooted in compromised mitochondrial function.

Top Connection closed successfully.